鹰制药公司
US ˙ OTCPK ˙ US2697961082

介绍

本页面提供了有关 Krill Steven L. 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Krill Steven L.已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:EGRX / Eagle Pharmaceuticals, Inc. EVP & Chief Scientific Officer 9,000
如何解读这些图表

以下图表显示了在Krill Steven L.进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

EGRX / Eagle Pharmaceuticals, Inc.内部人士买入 - 短期收益分析

在这一部分,我们分析了在 EGRX / Eagle Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报,以及是否值得跟踪。该分析基于每笔交易后一年的情况,结果仅为理论值

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最高利润的
天数
达到最高利润时的
价格
最高
利润($)
最高回报率(%)
当前未知该内部人士进行过任何未预先计划的公开市场交易。

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
EGRX / Eagle Pharmaceuticals, Inc.内部人士卖出 - 短期亏损分析

在这一部分,我们分析了在 EGRX / Eagle Pharmaceuticals, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式,可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况,

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数
报告
价格
经调整
股数
经调整
价格
成本基础 达到最低利润的
天数
达到最低利润时的
价格
避免的
最高损失金额($)
避免的
最高损失率($)
2017-03-23 EGRX Krill Steven L. 7,025 82.0625 7,025 82.0625 576,489 137 46.6200 -248,984 -43.19
2017-03-22 EGRX Krill Steven L. 7,100 80.0903 7,100 80.0903 568,641
2016-12-23 EGRX Krill Steven L. 5,127 78.6069 5,127 78.6069 403,018
2016-12-22 EGRX Krill Steven L. 5,126 76.7794 5,126 76.7794 393,571
2016-12-21 EGRX Krill Steven L. 2,683 77.1747 2,683 77.1747 207,060
2016-12-21 EGRX Krill Steven L. 7,569 77.1747 7,569 77.1747 584,135
2016-12-20 EGRX Krill Steven L. 10,000 76.6876 10,000 76.6876 766,876
2016-12-19 EGRX Krill Steven L. 2,683 75.6066 2,683 75.6066 202,853
2016-12-19 EGRX Krill Steven L. 7,317 75.6066 7,317 75.6066 553,213
2016-12-15 EGRX Krill Steven L. 3,730 74.7896 3,730 74.7896 278,965
2016-12-15 EGRX Krill Steven L. 6,270 74.7896 6,270 74.7896 468,931
2016-12-13 EGRX Krill Steven L. 10,000 73.6163 10,000 73.6163 736,163
2016-11-30 EGRX Krill Steven L. 1,950 80.0000 1,950 80.0000 156,000
2016-11-30 EGRX Krill Steven L. 2,530 80.0000 2,530 80.0000 202,400
2016-11-30 EGRX Krill Steven L. 1,307 80.0000 1,307 80.0000 104,560
2016-11-23 EGRX Krill Steven L. 200 80.0000 200 80.0000 16,000
2015-06-16 EGRX Krill Steven L. 5,850 81.6000 5,850 81.6000 477,360
2015-06-16 EGRX Krill Steven L. 2,730 81.6000 2,730 81.6000 222,768
2015-06-16 EGRX Krill Steven L. 1,400 81.6000 1,400 81.6000 114,240

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

EGRX / Eagle Pharmaceuticals, Inc. Insider Trades
内幕交易历史

该表格显示了由 Krill Steven L. 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Performance Stock Unit
A - Award 9,000 9,000
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
A - Award 15,000 15,000
2018-01-09 2018-01-07 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
A - Award 3,000 3,000
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -5,000 15,000 -25.00
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -2,025 4,850 -29.45
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,025 0 -100.00 82.06 -576,489
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 7,025 246.91 12.63 63,150 88,726
2017-03-24 2017-03-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,025 2,025 12.67 25,657 25,657
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -2,077 6,875 -23.20
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
M - Exercise -5,023 457 -91.66
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,100 0 -100.00 80.09 -568,641
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,077 7,100 41.35 12.67 26,316 89,957
2017-03-24 2017-03-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,023 5,023 4.42 22,202 22,202
2017-01-06 2017-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 42,000 42,000
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,127 53,464 -8.75
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,127 0 -100.00 78.61 -403,018
2017-01-04 2016-12-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,127 5,127 46.09 236,303 236,303
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,126 58,591 -8.04
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,126 0 -100.00 76.78 -393,571
2017-01-04 2016-12-22 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,126 5,126 46.09 236,257 236,257
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7,569 63,717 -10.62
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,683 20,000 -11.83
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,569 0 -100.00 77.17 -584,135
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,569 7,569 46.09 348,855 348,855
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,683 0 -100.00 77.17 -207,060
2017-01-04 2016-12-21 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,683 2,683 12.63 33,886 33,886
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10,000 22,683 -30.60
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,000 0 -100.00 76.69 -766,876
2017-01-04 2016-12-20 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 10,000 12.63 126,300 126,300
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -7,317 32,683 -18.29
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,683 8,952 -23.06
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -7,317 0 -100.00 75.61 -553,213
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,317 7,317 12.63 92,414 92,414
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,683 0 -100.00 75.61 -202,853
2017-01-04 2016-12-19 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,683 2,683 12.67 33,994 33,994
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -6,270 11,635 -35.02
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -3,730 5,480 -40.50
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -6,270 0 -100.00 74.79 -468,931
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 6,270 6,270 12.67 79,441 79,441
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -3,730 0 -100.00 74.79 -278,965
2017-01-04 2016-12-15 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 3,730 3,730 4.42 16,487 16,487
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -10,000 9,210 -52.06
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -10,000 0 -100.00 73.62 -736,163
2016-12-15 2016-12-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 10,000 4.42 44,200 44,200
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,307 19,210 -6.37
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,530 0 -100.00
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,950 0 -100.00
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,307 0 -100.00 80.00 -104,560
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,307 1,307 4.42 5,777 5,777
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,530 0 -100.00 80.00 -202,400
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,530 2,530 8.78 22,213 22,213
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,950 0 -100.00 80.00 -156,000
2016-12-02 2016-11-30 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,950 1,950 8.78 17,121 17,121
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -200 2,530 -7.33
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 0 -100.00 80.00 -16,000
2016-12-02 2016-11-23 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 200 200 8.78 1,756 1,756
2016-01-05 2016-01-04 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 62,100 62,100
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -1,400 20,517 -6.39
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -2,730 2,730 -50.00
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise -5,850 1,950 -75.00
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,400 0 -100.00 81.60 -114,240
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1,400 1,400 4.42 6,188 6,188
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,730 0 -100.00 81.60 -222,768
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,730 2,730 8.78 23,969 23,969
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
S - Sale -5,850 0 -100.00 81.60 -477,360
2015-06-18 2015-06-16 4 EGRX EAGLE PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,850 5,850 8.78 51,363 51,363
2015-03-17 2015-03-13 4 EGRX EAGLE PHARMACEUTICALS, INC.
Option (right to buy)
A - Award 71,286 71,286
2014-08-27 2014-08-26 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 40,000 40,000
2014-05-02 2014-04-08 4 EGRX EAGLE PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 17,905 17,905
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)